Analyst firms · Citizens JMP · ANTX

Citizens JMP ANTX price target and rating history

AN2 Therapeutics Inc. (ANTX) · Health Care

Citizens JMP rates AN2 Therapeutics Inc. (ANTX) Mkt Outperform with a $6 price target, as of its latest action on Apr 2, 2024. It has published 3 rating actions on ANTX since January 2024, including 1 upgrade and 1 downgrade.

Current rating
Mkt Outperform
Price target
$6
Median target, all firms
Too few
Actions on ANTX
3

Citizens JMP price target on ANTX

$30$18$620252026
Citizens JMP price target on ANTX, each point a stated target, January 2024 to April 2024.

Every Citizens JMP rating on ANTX

Questions about Citizens JMP and ANTX

What is Citizens JMP's price target for ANTX?
Citizens JMP's latest stated price target for AN2 Therapeutics Inc. (ANTX) is $6, from its action on Apr 2, 2024.
What is Citizens JMP's rating on ANTX?
Citizens JMP rates ANTX Mkt Outperform, a bullish rating, as of Apr 2, 2024.
When did Citizens JMP last change its view on ANTX?
On Apr 2, 2024, Citizens JMP upgrades to Mkt Outperform from Mkt Perform, price target $6.

More ANTX rating histories

All Citizens JMP ratingsANTX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.